Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$27.44 - $35.56 $53,041 - $68,737
-1,933 Reduced 11.98%
14,207 $416,000
Q4 2023

Feb 14, 2024

SELL
$28.47 - $38.49 $133,865 - $180,979
-4,702 Reduced 22.56%
16,140 $586,000
Q3 2023

Nov 14, 2023

SELL
$28.28 - $38.36 $120,218 - $163,068
-4,251 Reduced 16.94%
20,842 $668,000
Q2 2023

Aug 14, 2023

SELL
$17.67 - $31.31 $884,136 - $1.57 Million
-50,036 Reduced 66.6%
25,093 $785,000
Q1 2023

May 15, 2023

BUY
$17.13 - $38.52 $1.16 Million - $2.6 Million
67,497 Added 884.39%
75,129 $1.71 Million
Q4 2022

Feb 14, 2023

SELL
$29.44 - $37.31 $15,102 - $19,140
-513 Reduced 6.3%
7,632 $260,000
Q3 2022

Nov 14, 2022

SELL
$28.84 - $38.92 $96,181 - $129,798
-3,335 Reduced 29.05%
8,145 $248,000
Q2 2022

Aug 15, 2022

BUY
$33.25 - $45.11 $57,389 - $77,859
1,726 Added 17.7%
11,480 $427,000
Q1 2022

May 16, 2022

BUY
$40.68 - $49.72 $396,792 - $484,968
9,754 New
9,754 $442,000
Q4 2021

Feb 14, 2022

SELL
$43.21 - $57.6 $439,013 - $585,216
-10,160 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$52.8 - $60.32 $235,910 - $269,509
-4,468 Reduced 30.54%
10,160 $565,000
Q2 2021

Aug 16, 2021

BUY
$51.29 - $59.15 $216,546 - $249,731
4,222 Added 40.57%
14,628 $794,000
Q1 2021

May 17, 2021

BUY
$42.18 - $56.07 $118,567 - $157,612
2,811 Added 37.01%
10,406 $583,000
Q4 2020

Feb 16, 2021

SELL
$35.18 - $43.52 $126,049 - $155,932
-3,583 Reduced 32.05%
7,595 $331,000
Q3 2020

Nov 16, 2020

SELL
$37.98 - $48.72 $159,743 - $204,916
-4,206 Reduced 27.34%
11,178 $435,000
Q2 2020

Aug 17, 2020

BUY
$31.07 - $44.74 $158,612 - $228,397
5,105 Added 49.66%
15,384 $665,000
Q1 2020

May 15, 2020

SELL
$22.46 - $42.24 $314,799 - $592,035
-14,016 Reduced 57.69%
10,279 $342,000
Q4 2019

Feb 14, 2020

BUY
$39.01 - $47.51 $291,443 - $354,947
7,471 Added 44.41%
24,295 $1.01 Million
Q3 2019

Nov 14, 2019

BUY
$38.66 - $47.41 $650,415 - $797,625
16,824 New
16,824 $770,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $533M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.